Today: 9 June 2026
Rolls-Royce share price today: what to watch before London opens for RR.L
26 January 2026
1 min read

Rolls-Royce share price today: what to watch before London opens for RR.L

London, Jan 26, 2026, 07:47 GMT — Premarket

  • Rolls-Royce shares edged up slightly in London on Friday as the stock entered the new week.
  • Near-term focus centers on buyback mechanics and the upcoming results date.
  • Fresh warnings from Airbus have thrust aviation supply-chain issues back into the spotlight.

Shares of Rolls-Royce Holdings plc (RR.L) closed Friday 0.7% higher at 1,253 pence, having fluctuated between 1,246p and 1,262.5p during the session. Trading volume reached 37.1 million shares.

The FTSE 100 engineering firm has surged around 105% in the last year, currently trading about 4% shy of its 52-week peak at 1,306.5p. According to Hargreaves Lansdown, the company’s market capitalization stands near £103 billion, with a trailing P/E ratio close to 62.

That puts the stock vulnerable to minor changes in sentiment. Trading close to record highs, investors begin hunting for excuses to hold back.

Rolls-Royce announced in December an interim share buyback program of up to £200 million, starting Jan. 2 and set to conclude by Feb. 24 at the latest. The company plans to cancel all shares repurchased under this scheme.

Rolls-Royce is set to release its full-year 2025 results on Feb. 26.

The aviation sector showed fresh signs of strain after Airbus CEO Guillaume Faury flagged “significant” logistical and financial harm caused by trade tensions last year. In a memo obtained by Reuters, he pointed to Airbus’s “most serious difficulties” still lying with Pratt & Whitney and CFM engines, underscoring ongoing supply chain bottlenecks in the industry. Reuters

Rolls-Royce rides that cycle, with its civil aerospace division relying heavily on long-term service contracts once engines are in operation — generating “aftermarket” income through maintenance and parts. LSEG data also highlight its defence, power systems, and a “new markets” segment, which covers small modular reactors. Reuters

Traders will be eyeing the early action in UK industrials before the open, keeping a close watch on whether the buyback remains a reliable support when the stock dips. Lately, the shares have reacted swiftly to sector news.

The rally has tightened the margin for error on cash flow and any hint that aircraft delivery delays are returning to disrupt engine utilisation. Should February’s shareholder return package fall short of expectations, the downside risk will emerge quickly.

Stock Market Today

  • Pro Portfolio Adds Broadcom and Netflix Shares, Upgrades Broadcom Rating
    June 9, 2026, 10:19 AM EDT. The Pro Portfolio is buying 80 shares of Broadcom (AVGO) at around $405, increasing its holdings to 512 shares (3.4% of the portfolio). It is also purchasing 372 shares of Netflix (NFLX) near $82.35, increasing its stake to 2,107 shares (2.85%). Broadcom's AI chip forecast for H2 2026 is viewed as conservative following a $35 billion private credit deal involving Apollo and Blackstone. The rating for Broadcom is upgraded to One, with a checkpoint price of $330 maintained. Netflix's shares are seen as undervalued despite recent declines, supported by a $25 billion buyback and rising U.S. viewership. Netflix's ad business shows growth potential, reaching 250 million monthly active viewers, reinforcing optimism amidst concerns over consumer spending.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Netflix to Paramount: Your Warner Bros bid “doesn’t pass the sniff test” as takeover clock ticks
Previous Story

Netflix to Paramount: Your Warner Bros bid “doesn’t pass the sniff test” as takeover clock ticks

Lloyds Banking Group share price lifts as profit-target talk grows ahead of results
Next Story

Lloyds Banking Group share price lifts as profit-target talk grows ahead of results

Go toTop